Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will join of an expert panel of biotherapeutic leaders to discuss “Aligning Priorities with the Board” during the Longwood Healthcare Leaders Meeting.

Exacis has generated NK cells from iPSCs engineered using mRNA gene-editing technology to resist rejection by the patient’s immune system.